Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

NCT03014804 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Final contract negotiations

Conditions

Giant Cell Glioblastoma
Gliosarcoma
Oligodendroglioma
Recurrent Glioblastoma
Small Cell Glioblastoma

Interventions

BIOLOGICAL: autologous dendritic cells pulsed with tumor lysate antigen Vaccine
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]